Category: Cancer News

Lonsurf for advanced Colorectal cancer

Lonsurf is a pill that combines two drugs (trifluridine and tipiracil), for patients with advanced colorectal cancer.

Lonsurf has been shown to improve survival in patients with advanced colorectal cancer who have exhausted other therapies.

Lonsurf is a twice a day oral therapy taken for 10 out of 28  days.

It does have side-effects which include neutropenia, anaemia, thrombocytopenia and tiredness. Other side-effects include those typically seen with other fluoropyrimidines such as 5FU.

Low dose aspirin reduces risk of recurrence of colon cancer

A study in the Annals of Internal Medicine (Aug 24 2015) found that in a group of Danish patients who after colon cancer took low dose aspirin or NSAID there was a 27% reduced risk of colon cancer recurrence.

This effect was seen in the group who took the medication long term.

Dr Zimet thinks that this may be a reasonable treatment for patients with prior colon cancer if there is no contraindication to therapy.

Read further here.